Sugi Predict

Sugi Predict / Compounds / SCHEMBL32676360

SCHEMBL32676360

SCHEMBL32676360

CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(N)=O

nearest known ligand 0.63

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ EP300 Q09472 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ NPY2R P49146 7/20 0.56
▸ NPY4R P50391 7/20 0.56
▸ NPY5R Q15761 7/20 0.56
▸ NPY1R P25929 6/20 0.56
▸ EPHA2 P29317 2/20 0.56
▸ MAPK8 P45983 1/20 0.56
▸ MAPK9 P45984 1/20 0.56
▸ MAPK10 P53779 1/20 0.56
▸ NMUR2 Q9GZQ4 2/20 0.55
▸ NMUR1 Q9HB89 2/20 0.55
▸ CXCR4 P61073 3/20 0.54
▸ CALCR P30988 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30712780 0.96 NPY2R (0.58) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL30963695 0.96 MAPK8 (0.58) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL30712788 0.93 EP300 (0.56) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL30525422 0.89 EPHA2 (0.57) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL30618029 0.88 CALCR (0.66) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL30618027 0.88 NPY2R (0.67) NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31651397 0.87 NPY2R (0.71) NPY2RNPY4RNPY5RNPY1RMAPK8
SCHEMBL30788350 0.87 NMUR2 (0.58) EPHA2NMUR2NMUR1CXCR4CALCR
SCHEMBL30887079 0.87 CXCR4 (0.51) EP300HIF1ANPY2RNPY4RNPY5R
SCHEMBL31000921 0.86 NPY2R (0.63) EP300HIF1ANPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260048130-A1 ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY ALNYLAM PHARMACEUTICALS INC (US) 2026-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048130-A1 ALPHA-V BETA-6 (avb6) INTEGRIN LIGANDS FOR EXTRAHEPATIC DELIVERY ITGB6, ITGA6, ITGA2B EP300 4306/4885HIF1A 2349/4885NPY2R 3709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback